167 related articles for article (PubMed ID: 16480587)
1. [Clinical analysis of 1,142 hospitalized cantonese patients with nasopharyngeal carcinoma].
Cao SM; Guo X; Li NW; Xiang YQ; Hong MH; Min HQ
Ai Zheng; 2006 Feb; 25(2):204-8. PubMed ID: 16480587
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
Ling W; Cao SM; Huang QH; Li YH; Deng MQ
Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
[TBL] [Abstract][Full Text] [Related]
3. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China.
Jia WH; Feng BJ; Xu ZL; Zhang XS; Huang P; Huang LX; Yu XJ; Feng QS; Yao MH; Shugart YY; Zeng YX
Cancer; 2004 Jul; 101(2):363-9. PubMed ID: 15241835
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
5. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients].
Ji MF; Guo YQ; Liang JS; Zheng SA; Cheng WM; Yu BH; Ou XT; Wang DK
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):243-5. PubMed ID: 12839685
[TBL] [Abstract][Full Text] [Related]
6. Serological survey of nasopharyngeal carcinoma in 21 cities of south China.
Deng H; Zeng Y; Lei Y; Zhao Z; Wang P; Li B; Pi Z; Tan B; Zheng Y; Pan W
Chin Med J (Engl); 1995 Apr; 108(4):300-3. PubMed ID: 7789220
[TBL] [Abstract][Full Text] [Related]
7. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiological study of nasopharyngeal carcinoma risk in relatives of high-risk families in Guangdong].
Jia WH; Xu ZL; Feng BJ; Huang LX; Yu XJ; Feng QS; Zhang F; Zeng YX
Ai Zheng; 2004 Jul; 23(7):767-70. PubMed ID: 15248909
[TBL] [Abstract][Full Text] [Related]
10. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
11. [Nasopharyngeal carcinoma (NPC) mortality rate in two districts of Guangdong Province and their relation to IgA antibody level against EB virus capsid antigen].
Zong YS
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):103-5. PubMed ID: 1319889
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
[TBL] [Abstract][Full Text] [Related]
13. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study on risk factors and family history of familial and sporadic nasopharyngeal carcinoma patients].
Luo XY; Liu WS; Chen LZ; Feng QS; Zeng YX; Jia WH
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):293-8. PubMed ID: 19534949
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
17. Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China).
Jia WH; Collins A; Zeng YX; Feng BJ; Yu XJ; Huang LX; Feng QS; Huang P; Yao MH; Shugart YY
Eur J Hum Genet; 2005 Feb; 13(2):248-52. PubMed ID: 15483644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus seroepidemiology in China.
Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
Zhang C; Zong Y; Huang B; Sun Y; Ye Y; Feng K; Li J; Zhang F
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):356-9. PubMed ID: 12408763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
